The risk profile change in patients with severe chronic thromboembolic pulmonary hypertension treated with subcutaneous treprostinil by Pavel Jansa, Grzegorz Kopeć, Adam Torbicki, Roela Sadushi‐Kolici, Ioana‐Alexandra Campean, Michael Halank, Iveta Simkova, Regina Steringer‐Mascherbauer, Barbara Salobir, Walter Klepetko, Jaroslav Lindner, Irene M. Lang

Get full text